Sinai Health (McIntyre, Fralick), Toronto, Ont.; Leslie Dan Faculty of Pharmacy (McIntyre), University of Toronto; Li Ka Shing Knowledge Institute (Saha, Verma, Razak), St. Michael's Hospital, Toronto, Ont.; Department of Social and Behavioral Sciences (Saha), Harvard T.H. Chan School of Public Health, Boston, Mass.; Department of Medicine (Morris, Lapointe-Shaw, Weinerman, Fralick, Verma, Razak), University of Toronto; Department of Medicine (Morris), Mount Sinai Hospital and University Health Network; Department of Medicine (Lapointe-Shaw), University Health Network, Toronto, Ont.; Trillium Health Partners (Tang), Mississauga, Ont.; Department of Medicine (Weinerman), Sunnybrook Health Sciences Centre; Division of General Internal Medicine (Agarwal); Department of Medicine (Agarwal), McMaster University, Hamilton, Ont.
CMAJ. 2023 Aug 21;195(32):E1065-E1074. doi: 10.1503/cmaj.221732.
Variability in antimicrobial prescribing may indicate an opportunity for improvement in antimicrobial use. We sought to measure physician-level antimicrobial prescribing in adult general medical wards, assess the contribution of patient-level factors to antimicrobial prescribing and evaluate the association between antimicrobial prescribing and clinical outcomes.
Using the General Medicine Inpatient Initiative (GEMINI) database, we conducted a retrospective cohort study of physician-level volume and spectrum of antimicrobial prescribing in adult general medical wards in 4 academic teaching hospitals in Toronto, Ontario, between April 2010 and December 2019. We stratified physicians into quartiles by hospital site based on volume of antimicrobial prescribing (days of therapy per 100 patient-days and antimicrobial-free days) and antibacterial spectrum (modified spectrum score). The modified spectrum score assigns a value to each antibacterial agent based on the breadth of coverage. We assessed patient-level differences among physician quartiles using age, sex, Laboratory-based Acute Physiology Score, discharge diagnosis and Charlson Comorbidity Index. We evaluated the association of clinical outcomes (in-hospital 30-day mortality, length of stay, intensive care unit [ICU] transfer and hospital readmission) with antimicrobial volume and spectrum using multilevel modelling.
The cohort consisted of 124 physicians responsible for 124 158 hospital admissions. The median physician-level volume of antimicrobial prescribing was 56.1 (interquartile range 51.7-67.5) days of therapy per 100 patient-days. We did not find any differences in baseline patient characteristics by physician prescribing quartile. The difference in mean prescribing between quartile 4 and quartile 1 was 15.8 days of therapy per 100 patient-days (95% confidence interval [CI] 9.6-22.0), representing 30% higher antimicrobial prescribing in the fourth quartile than the first quartile. Patient in-hospital deaths, length of stay, ICU transfer and hospital readmission did not differ by physician quartile. In-hospital mortality was higher among patients cared for by prescribers with higher modified spectrum scores (odds ratio 1.13, 95% CI 1.04-1.24).
We found that physician-level variability in antimicrobial prescribing was not associated with differences in patient characteristics or outcomes in academic general medicine wards. These findings provide support for considering the lowest quartile of physician antimicrobial prescribing within each hospital as a target for antimicrobial stewardship.
抗菌药物使用的变异性可能表明有改善的机会。我们旨在测量成人普通内科病房医生层面的抗菌药物使用量,评估患者层面因素对抗菌药物使用的贡献,并评估抗菌药物使用与临床结果之间的关联。
我们利用安大略省多伦多市 4 家学术教学医院的 General Medicine Inpatient Initiative (GEMINI) 数据库,对 2010 年 4 月至 2019 年 12 月期间成人普通内科病房医生层面的抗菌药物使用量和范围进行了回顾性队列研究。我们根据抗菌药物使用量(每 100 个患者日治疗天数和无抗菌药物天数)和抗菌谱(改良谱评分)将医生分为四分位数。改良谱评分根据覆盖范围的广度为每种抗菌药物分配一个值。我们使用年龄、性别、基于实验室的急性生理学评分、出院诊断和 Charlson 合并症指数评估医生四分位数间的患者水平差异。我们使用多层次建模评估临床结果(院内 30 天死亡率、住院时间、重症监护病房[ICU]转科和医院再入院)与抗菌药物量和谱之间的关联。
该队列包括 124 名负责 124158 例住院的医生。医生层面的抗菌药物使用量中位数为 56.1(四分位间距为 51.7-67.5)个治疗日/100 个患者日。我们没有发现医生处方四分位间患者特征存在任何差异。四分位 4 与四分位 1 之间的平均处方差异为 15.8 个治疗日/100 个患者日(95%置信区间[CI]为 9.6-22.0),第四四分位的抗菌药物使用量比第一四分位高 30%。患者院内死亡、住院时间、ICU 转科和医院再入院与医生四分位间无差异。使用改良谱评分较高的医生治疗的患者院内死亡率更高(比值比 1.13,95%CI 1.04-1.24)。
我们发现,成人普通内科病房医生层面抗菌药物使用量的变异性与患者特征或结果无差异。这些发现为考虑将每家医院最低四分位的医生抗菌药物使用量作为抗菌药物管理的目标提供了支持。